Mechanisms in neurodegenerative disorders and role of non-pharmacological interventions in improving neurodegeneration and its clinical correlates: A review

Sheng Mai

2023-08-09

Abstract:Mild cognitive impairment (MCI) leading to dementia results in a constellation of psychiatric disorders including depression, mood disorders, schizophrenia and others. With increasing age, mild cognitive impairment leads to increased disability-adjusted life-years and healthcare burden. A huge number of drug trials for the treatment of MCI associated with Alzheimer's disease have undergone failure leading to the development of drugs that could avert the progression of the disease. However, some novel non-drug-based therapies like ultrasound ablation of amyloid plaques have influenced researchers to explore the non-pharmacological modalities for the treatment of mild cognitive impairment. To compensate for neurodegenerative loss resulting in coexisting psychiatric disorders, neurofeedback therapy has also been proven to improve behavioural outcomes by inducing neuroplasticity. The aim of the current review is to highlight the pathophysiological aspects of mild cognitive impairment leading to dementia that could be addressed with no pharmacological interventions and to understand the mechanisms behind the effects of these interventions.

Neurons and Cognition

What problem does this paper attempt to address?

The paper attempts to address the pathophysiological mechanisms by which mild cognitive impairment (MCI) leads to dementia and its associated mental illnesses (such as depression, mood disorders, schizophrenia, etc.), and to explore the role of non-pharmacological interventions in improving these symptoms. Specifically, the paper focuses on the following aspects:

1. **Pathophysiological Mechanisms**: The paper discusses in detail the electrophysiological basis of how MCI leads to dementia, including changes in brain waves, alterations in neuronal function, and the biochemical mechanisms of neurodegenerative diseases.

2. **Effects of Non-Pharmacological Interventions**: The paper evaluates the efficacy of various non-pharmacological treatments for patients with MCI and dementia, including cognitive stimulation therapy, psychotherapy, aromatherapy, art therapy, music therapy, technology-assisted therapies (such as ultrasound, photobiomodulation, virtual reality), and neurofeedback therapy.

3. **Clinical Relevance**: The paper also explores the clinical application prospects of these non-pharmacological interventions and how they can improve the quality of life for patients.

Through these studies, the paper aims to provide new ideas and methods for the treatment of MCI and dementia, particularly those non-pharmacological interventions that can reduce drug side effects and are cost-effective.